Parallax Volatility Advisers, L.P. Bio N Tech Se Transaction History
Parallax Volatility Advisers, L.P.
- $35.7 Billion
- Q1 2025
A detailed history of Parallax Volatility Advisers, L.P. transactions in Bio N Tech Se stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 634 shares of BNTX stock, worth $73,315. This represents 0.0% of its overall portfolio holdings.
Number of Shares
634
Previous 23,827
97.34%
Holding current value
$73,315
Previous $2.72 Million
97.9%
% of portfolio
0.0%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding BNTX
# of Institutions
340Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$944 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$493 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$468 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$219 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$209 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...